Cubist in the News

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) announced on May 19th that it was ranked first among the "Top 100" Massachusetts-based publicly traded companies by The Boston Globe in its 21st annual "Globe 100" listing released on May 19th. Cubist is only the third life sciences company in Massachusetts to appear at the top of the Globe 100 rankings, and as a company that researches, develops, and brings to market pharmaceutical products, is the first of its kind to achieve this distinction.
Click here for the full press release
Click here for video on Boston.com
Click here for The Boston Globe "Globe 100: The Cure No One Saw", Tuesday, May 19, 2009
Click here for NECN's report of Cubist's spot in Boston Globe's 100

• Lexington Minuteman - Cubist to Expand, November 10, 2009
• Cubist Pharmaceuticals Wins Top Honors in the Sixth Annual Team Massachusetts Economic Impact Awards, October 9, 2009
• Lexington Minuteman highlights Cubist program to honor science teachers, August 17, 2009
• Lexington Minuteman "Lexington's commercial sector could undergo big changes", August 6, 2009
• Boston Business Journal "Cubist seeks to boost Lexington lab space", August 5, 2009
• Mike Bonney appeared on New England Cable News' (NECN) "This Week in Business", June 21, 2009
• Barry Eisenstein, M.D., featured in Life Science Leader, March 2009
• Drug Maker Targets Infections That Are Resistant to Antibiotics, Investor's Business Daily, November 2008
• Mike Bonney is featured in Pharmaceutical Executive, October 2008
• Cubist's VP of Chemistry, Dennis Keith, is featured in the PharmaVOICE100 listing, July 2008

See also more news about Cubist.